Correction to "Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia".

doi:10.1002/cncr.70347

← 뒤로

Correction to "Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia".

0/5 보강

Cancer 📖 저널 OA 38.5% 2022~2026 2026 Vol.132(6) p. e70347

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA (2026). Correction to "Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia".. Cancer, 132(6), e70347. https://doi.org/10.1002/cncr.70347

MLA . "Correction to "Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia".." Cancer, vol. 132, no. 6, 2026, pp. e70347.

PMID 41823509 ↗

DOI 10.1002/cncr.70347